e-learning
resources
Milan 2017
Monday, 11.09.2017
Efficacy of and compliance with obstructive sleep apnoea treatment
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Effect of CPAP therapy on neutrophil to lymphocyte ratio and platelet to lymphocyte ratio in patients with obstructive sleep apnea.
S. Sökücü (Istanbul, Turkey)
Source:
International Congress 2017 – Efficacy of and compliance with obstructive sleep apnoea treatment
Session:
Efficacy of and compliance with obstructive sleep apnoea treatment
Session type:
Thematic Poster
Number:
2275
Disease area:
Sleep and breathing disorders
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
S. Sökücü (Istanbul, Turkey). Effect of CPAP therapy on neutrophil to lymphocyte ratio and platelet to lymphocyte ratio in patients with obstructive sleep apnea.. 2275
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
The Relationship Between Functional Status and Fatigue After COVID-19 Infection
Late Breaking Abstract - Implications of treatable traits and treatment choices on exacerbation risk in moderate-severe asthma
Impact of Dexamethasone on pathogen profile of COVID-19 patients requiring intensive care: a multicentre retrospective study
Related content which might interest you:
Effect of nCPAP therapy on inflammatory cell counts in pharyngeal lavage of patients with obstructive sleep apnea
Source: Annual Congress 2009 - Assessment and therapeutical interventions in obstructive sleep apnoea
Year: 2009
Neutrophil to lymphocyte ratio and platelet to lymphocyte ratio in patients with acute exacerbation of chronic obstructive pulmonary disease
Source: International Congress 2018 – Biomarkers for evaluating COPD
Year: 2018
The association between hypertension and neutrophil to lymphocyte ratio in patients with obstructive sleep apnea syndrome
Source: International Congress 2016 – Effects of hypoxia and sleep apnoea on the lung, heart, and vessels
Year: 2016
Importance of neutrophil to lymphocyte ratio and platelet to lymphocyte ratio in COPD exacerbations
Source: International Congress 2017 – COPD and weaning
Year: 2017
Treatment of obstructive sleep apnea and the cytotoxic potential in peripheral blood lymphocytes
Source: Eur Respir J 2001; 18: Suppl. 33, 334s
Year: 2001
Mean platelet volume in patients with obstructive sleep apnea syndrome
Source: Annual Congress 2010 - Nocturnal cardiology: chronic heart failure, acute chest syndrome, coronary artery disease and collagen vascular disease
Year: 2010
Effects of nasal continuous positive airway pressure treatment on C-reactive protein in patients with obstructive sleep apnea
Source: Annual Congress 2009 - Systemic consequences of sleep-disordered breathing
Year: 2009
Activated CD8 T-lymphocytes in obstructive sleep apnoea
Source: Eur Respir J 2005; 25: 820-828
Year: 2005
Mean platelet volume in obstructive sleep apnea patients. Another link to cardiovascular disease?
Source: Annual Congress 2011 - Obstructive sleep apnoea: the heart and the brain
Year: 2011
Endothelial and systemic inflammation in obstructive sleep apnea syndrome: Impact of CPAP therapy on CRP plasma levels
Source: Annual Congress 2010 - Biomarkers for oxidative stress, inflammation and cardiovascular function in sleep apnoea
Year: 2010
Liver function following continuous positive airway pressure therapy in obstructive sleep apnea patients
Source: International Congress 2017 – CPAP therapy
Year: 2017
Effects of reduced lung volumes and age on oxyhemoglobin nocturnal desaturation in obstructive sleep apnea patients before and after CPAP treatment
Source: Annual Congress 2011 - Obstructive sleep apnoea: clinical aspects II
Year: 2011
Mean platelet volume and platelet distribution width in patients with obstructive sleep apnea syndrome and chronic obstructive pulmonary disease (overlap syndrome)
Source: International Congress 2018 – From continuous positive airway pressure (CPAP) and adherence to CPAP to asthma-COPD overlap syndrome (ACOS)
Year: 2018
Circulating dendritic cell subsets are reduced in obstructive sleep apnoea patients: study correlation with inflammation markers
Source: International Congress 2019 – Consequences of sleep-disordered breathing from molecular and clinical points of view
Year: 2019
Monocytes inhibit NK activity
via
TGF-ß in patients with obstructive sleep apnoea
Source: Eur Respir J, 49 (6) 1602456; 10.1183/13993003.02456-2016
Year: 2017
The lymphocyte subset analysis in patients with arterial hypertension and severe obstructive sleep apnea syndrome
Source: Annual Congress 2012 - Physiology, obesity and the downstream effects of OSA
Year: 2012
Mean platelet volume in patients with obstructive sleep apnea syndrome and its relationship with cardiovasculer diseases
Source: Annual Congress 2011 - Comorbid obstructive sleep apnoea (OSA) and OSA comorbidities
Year: 2011
Effect and significance of continuous positive airway pressure treatment on vascular endothelial function in patients with obstructive sleep apnoea syndrome
Source: Annual Congress 2003 - Systematic inflammation and metabolic disorders in sleep related breathing disorders
Year: 2003
The effect of theophylline and CPAP on cytokine release in patients with obstructive sleep apnea syndrome (OSAS)
Source: Eur Respir J 2006; 28: Suppl. 50, 216s
Year: 2006
Effect of continuous positive airway pressure treatment (CPAP) in angiogenic growth factors‘ expression in patients with COPD and obstructive sleep apnea syndrome (OSAS)
Source: Annual Congress 2010 - Recent developments of molecular pathology and functional genomics in chronic and acute airway diseases
Year: 2010
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept